Connect with us

Psychedelics

Terran Biosciences Files New Patent on First Salts and Polymorphs for 4-OH-DiPT

A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT.
The…

Published

on

This article was originally published by Microdose

A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT, adding another layer of IP intrigue around the lesser-known but potentially important compound.

Salts and Solid Forms of 4-Hydroxy-N,N-Diisopropyltryptamine Hemi-Glutarate and Hemi-Succinate was filed by Terran Biosciences and has claims on salts and polymorphs of 4-OH-DiPT, the same compound that both Mindset Pharma and Reunion Neuroscience have applied for patent claims on.

4-HO-DiPT is a psilocybin-like compound initially researched by the Shulgins and noted for its intense effects and shorter onset and trip time. Reunion and Mindset have been competing over patent claims on this drug, with Reunion recently suing Mindset Pharma over its competing patent.

Terran has been quite busy expanding its development portfolio and IP strategy with several recent announcements (see below). This recent publication marks another milestone from Terran’s chemistry team who have built a robust solid-state chemistry platform. So while companies like Reunion and Mindset Pharma have been publicly dueling over the IP around this compound, it appears that Terran had been working on making advances to the compound’s chemistry and developing these novel approaches that, to our knowledge, others have not yet pursued.

While Terran is developing many compounds in-house, they have announced that they’ve made large data packages and IP portfolios available for licensing and partnerships to help advance the psychedelic industry as a whole, which would certainly be of interest to other companies looking to accelerate the development of their pipelines.

 

 

 

For more on Terran, check out Terran Biosciences announces publication of four patent applications of novel empathogens and Terran Biosciences Announces Licensing Deal with Pierre Fabre for Idazoxan; Completes Development Milestones

The post Terran Biosciences Files New Patent on First Salts and Polymorphs for 4-OH-DiPT appeared first on Microdose.

psilocybin
psychedelic

Psychedelics

Psychedelic Search Trends in 2023

Take a look at this 2023 search volume chart. Do you think you can guess what’s happening? I was pretty shocked when I noticed this spike for December…

Continue Reading
Psychedelics

Here Are the Champions! Our Top Performing Stories in 2023

It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…

Continue Reading
Psychedelics

Psilocybin shows promise for treating eating disorders, but more controlled research is needed

Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted…

Continue Reading

Trending